CN104547960A - Qi tonifying and meridian unblocking medicament for patients with hyperlipidemia and preparation method of medicament - Google Patents
Qi tonifying and meridian unblocking medicament for patients with hyperlipidemia and preparation method of medicament Download PDFInfo
- Publication number
- CN104547960A CN104547960A CN201510063562.5A CN201510063562A CN104547960A CN 104547960 A CN104547960 A CN 104547960A CN 201510063562 A CN201510063562 A CN 201510063562A CN 104547960 A CN104547960 A CN 104547960A
- Authority
- CN
- China
- Prior art keywords
- parts
- preferred
- minute
- fructus
- herba
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 66
- 238000002360 preparation method Methods 0.000 title claims description 31
- 208000031226 Hyperlipidaemia Diseases 0.000 title abstract description 23
- 239000002994 raw material Substances 0.000 claims abstract description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 55
- 210000000582 semen Anatomy 0.000 claims description 50
- 239000000706 filtrate Substances 0.000 claims description 46
- 230000001502 supplementing effect Effects 0.000 claims description 41
- 230000003516 hyperlipidaemic effect Effects 0.000 claims description 36
- 235000019991 rice wine Nutrition 0.000 claims description 32
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 26
- 239000000203 mixture Substances 0.000 claims description 26
- 239000000843 powder Substances 0.000 claims description 24
- 150000003839 salts Chemical class 0.000 claims description 20
- 229910052742 iron Inorganic materials 0.000 claims description 13
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 12
- 239000002775 capsule Substances 0.000 claims description 12
- 239000011521 glass Substances 0.000 claims description 12
- 239000011780 sodium chloride Substances 0.000 claims description 12
- 239000007921 spray Substances 0.000 claims description 12
- 239000006228 supernatant Substances 0.000 claims description 12
- 238000005242 forging Methods 0.000 claims description 11
- 235000013339 cereals Nutrition 0.000 claims description 9
- 229940079593 drug Drugs 0.000 claims description 9
- 238000007654 immersion Methods 0.000 claims description 8
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 claims description 8
- 235000010234 sodium benzoate Nutrition 0.000 claims description 8
- 239000004299 sodium benzoate Substances 0.000 claims description 8
- 239000007788 liquid Substances 0.000 claims description 7
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims description 5
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims description 5
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims description 5
- 229960002675 xylitol Drugs 0.000 claims description 5
- 235000010447 xylitol Nutrition 0.000 claims description 5
- 239000000811 xylitol Substances 0.000 claims description 5
- 238000002156 mixing Methods 0.000 claims description 4
- 239000008187 granular material Substances 0.000 claims description 3
- 238000012545 processing Methods 0.000 claims description 3
- 239000007779 soft material Substances 0.000 claims description 3
- 238000009495 sugar coating Methods 0.000 claims description 3
- 210000004369 blood Anatomy 0.000 abstract description 18
- 239000008280 blood Substances 0.000 abstract description 18
- 230000001737 promoting effect Effects 0.000 abstract description 13
- 230000017531 blood circulation Effects 0.000 abstract description 9
- 150000002632 lipids Chemical class 0.000 abstract description 9
- 210000000952 spleen Anatomy 0.000 abstract description 9
- 235000013399 edible fruits Nutrition 0.000 abstract description 6
- 206010062717 Increased upper airway secretion Diseases 0.000 abstract description 3
- 230000006870 function Effects 0.000 abstract description 3
- 239000000463 material Substances 0.000 abstract description 3
- 208000026435 phlegm Diseases 0.000 abstract description 3
- 244000105624 Arachis hypogaea Species 0.000 abstract description 2
- 241001289529 Fallopia multiflora Species 0.000 abstract description 2
- 241000237502 Ostreidae Species 0.000 abstract description 2
- 230000004087 circulation Effects 0.000 abstract description 2
- 230000003071 parasitic effect Effects 0.000 abstract description 2
- 244000153885 Appio Species 0.000 abstract 1
- 235000010591 Appio Nutrition 0.000 abstract 1
- 235000017060 Arachis glabrata Nutrition 0.000 abstract 1
- 235000010777 Arachis hypogaea Nutrition 0.000 abstract 1
- 235000018262 Arachis monticola Nutrition 0.000 abstract 1
- 235000009024 Ceanothus sanguineus Nutrition 0.000 abstract 1
- 235000000604 Chrysanthemum parthenium Nutrition 0.000 abstract 1
- 244000164480 Curcuma aromatica Species 0.000 abstract 1
- 235000003398 Curcuma aromatica Nutrition 0.000 abstract 1
- 241000110637 Cuscuta chinensis Species 0.000 abstract 1
- 240000002943 Elettaria cardamomum Species 0.000 abstract 1
- 240000007890 Leonurus cardiaca Species 0.000 abstract 1
- 235000000802 Leonurus cardiaca ssp. villosus Nutrition 0.000 abstract 1
- 240000003553 Leptospermum scoparium Species 0.000 abstract 1
- 241000830535 Ligustrum lucidum Species 0.000 abstract 1
- 241000488974 Loranthus Species 0.000 abstract 1
- 235000015459 Lycium barbarum Nutrition 0.000 abstract 1
- 240000007651 Rubus glaucus Species 0.000 abstract 1
- 235000011034 Rubus glaucus Nutrition 0.000 abstract 1
- 235000009122 Rubus idaeus Nutrition 0.000 abstract 1
- 235000002594 Solanum nigrum Nutrition 0.000 abstract 1
- 240000002307 Solanum ptychanthum Species 0.000 abstract 1
- 235000005300 cardamomo Nutrition 0.000 abstract 1
- 235000020636 oyster Nutrition 0.000 abstract 1
- 235000020232 peanut Nutrition 0.000 abstract 1
- 238000011282 treatment Methods 0.000 description 51
- 230000000694 effects Effects 0.000 description 26
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 20
- 210000003734 kidney Anatomy 0.000 description 19
- 108010023302 HDL Cholesterol Proteins 0.000 description 18
- 208000024891 symptom Diseases 0.000 description 16
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 16
- 210000004185 liver Anatomy 0.000 description 12
- 235000009508 confectionery Nutrition 0.000 description 10
- 230000003203 everyday effect Effects 0.000 description 9
- 206010020772 Hypertension Diseases 0.000 description 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 8
- 241000196324 Embryophyta Species 0.000 description 7
- 201000010099 disease Diseases 0.000 description 7
- 201000005577 familial hyperlipidemia Diseases 0.000 description 7
- 210000004072 lung Anatomy 0.000 description 7
- 230000027939 micturition Effects 0.000 description 7
- 210000002966 serum Anatomy 0.000 description 7
- 208000002173 dizziness Diseases 0.000 description 6
- 206010025482 malaise Diseases 0.000 description 6
- 210000002784 stomach Anatomy 0.000 description 6
- 241001253208 Andrias davidianus Species 0.000 description 5
- 208000029078 coronary artery disease Diseases 0.000 description 5
- 230000007812 deficiency Effects 0.000 description 5
- 230000009467 reduction Effects 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 201000001320 Atherosclerosis Diseases 0.000 description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 4
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 4
- 210000001015 abdomen Anatomy 0.000 description 4
- 206010003549 asthenia Diseases 0.000 description 4
- 210000000988 bone and bone Anatomy 0.000 description 4
- 239000008103 glucose Substances 0.000 description 4
- 206010022437 insomnia Diseases 0.000 description 4
- 210000003127 knee Anatomy 0.000 description 4
- 210000003141 lower extremity Anatomy 0.000 description 4
- 235000013372 meat Nutrition 0.000 description 4
- 210000002381 plasma Anatomy 0.000 description 4
- 231100000614 poison Toxicity 0.000 description 4
- 239000003826 tablet Substances 0.000 description 4
- 239000003440 toxic substance Substances 0.000 description 4
- 208000005171 Dysmenorrhea Diseases 0.000 description 3
- 206010013935 Dysmenorrhoea Diseases 0.000 description 3
- 108090001030 Lipoproteins Proteins 0.000 description 3
- 102000004895 Lipoproteins Human genes 0.000 description 3
- 208000002193 Pain Diseases 0.000 description 3
- 206010033557 Palpitations Diseases 0.000 description 3
- 206010033645 Pancreatitis Diseases 0.000 description 3
- 208000004880 Polyuria Diseases 0.000 description 3
- 208000009205 Tinnitus Diseases 0.000 description 3
- 235000019789 appetite Nutrition 0.000 description 3
- 230000036528 appetite Effects 0.000 description 3
- 210000004204 blood vessel Anatomy 0.000 description 3
- 235000012000 cholesterol Nutrition 0.000 description 3
- 230000001276 controlling effect Effects 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 206010012601 diabetes mellitus Diseases 0.000 description 3
- 235000005911 diet Nutrition 0.000 description 3
- 230000035619 diuresis Effects 0.000 description 3
- 206010013781 dry mouth Diseases 0.000 description 3
- 210000003414 extremity Anatomy 0.000 description 3
- 230000004438 eyesight Effects 0.000 description 3
- 230000001605 fetal effect Effects 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 238000007689 inspection Methods 0.000 description 3
- 230000033001 locomotion Effects 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 210000003205 muscle Anatomy 0.000 description 3
- 231100000862 numbness Toxicity 0.000 description 3
- 230000035935 pregnancy Effects 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 230000035922 thirst Effects 0.000 description 3
- 231100000886 tinnitus Toxicity 0.000 description 3
- GRWFGVWFFZKLTI-IUCAKERBSA-N 1S,5S-(-)-alpha-Pinene Natural products CC1=CC[C@@H]2C(C)(C)[C@H]1C2 GRWFGVWFFZKLTI-IUCAKERBSA-N 0.000 description 2
- 201000000736 Amenorrhea Diseases 0.000 description 2
- 206010001928 Amenorrhoea Diseases 0.000 description 2
- 206010008190 Cerebrovascular accident Diseases 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 208000008967 Enuresis Diseases 0.000 description 2
- WEEGYLXZBRQIMU-UHFFFAOYSA-N Eucalyptol Chemical compound C1CC2CCC1(C)OC2(C)C WEEGYLXZBRQIMU-UHFFFAOYSA-N 0.000 description 2
- 206010023126 Jaundice Diseases 0.000 description 2
- 239000010296 Jiang-Zhi-Ning Substances 0.000 description 2
- 206010027514 Metrorrhagia Diseases 0.000 description 2
- 206010059013 Nocturnal emission Diseases 0.000 description 2
- 206010067171 Regurgitation Diseases 0.000 description 2
- 206010041497 Spermatorrhoea Diseases 0.000 description 2
- 208000006011 Stroke Diseases 0.000 description 2
- 206010042434 Sudden death Diseases 0.000 description 2
- 206010044302 Tracheitis Diseases 0.000 description 2
- 206010046788 Uterine haemorrhage Diseases 0.000 description 2
- 206010046910 Vaginal haemorrhage Diseases 0.000 description 2
- 206010047531 Visual acuity reduced Diseases 0.000 description 2
- 206010048214 Xanthoma Diseases 0.000 description 2
- 206010048215 Xanthomatosis Diseases 0.000 description 2
- 208000005946 Xerostomia Diseases 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 238000005054 agglomeration Methods 0.000 description 2
- 230000002776 aggregation Effects 0.000 description 2
- 231100000540 amenorrhea Toxicity 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- UAHWPYUMFXYFJY-UHFFFAOYSA-N beta-myrcene Chemical compound CC(C)=CCCC(=C)C=C UAHWPYUMFXYFJY-UHFFFAOYSA-N 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 2
- 201000001883 cholelithiasis Diseases 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000008021 deposition Effects 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 238000001647 drug administration Methods 0.000 description 2
- 201000006549 dyspepsia Diseases 0.000 description 2
- 206010016256 fatigue Diseases 0.000 description 2
- 150000007946 flavonol Chemical class 0.000 description 2
- HVQAJTFOCKOKIN-UHFFFAOYSA-N flavonol Natural products O1C2=CC=CC=C2C(=O)C(O)=C1C1=CC=CC=C1 HVQAJTFOCKOKIN-UHFFFAOYSA-N 0.000 description 2
- 235000011957 flavonols Nutrition 0.000 description 2
- 210000000232 gallbladder Anatomy 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 208000006454 hepatitis Diseases 0.000 description 2
- 231100000283 hepatitis Toxicity 0.000 description 2
- 201000001881 impotence Diseases 0.000 description 2
- 238000011835 investigation Methods 0.000 description 2
- 239000007937 lozenge Substances 0.000 description 2
- 201000007227 lymph node tuberculosis Diseases 0.000 description 2
- 230000005906 menstruation Effects 0.000 description 2
- 208000010125 myocardial infarction Diseases 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 230000000630 rising effect Effects 0.000 description 2
- NDVASEGYNIMXJL-UHFFFAOYSA-N sabinene Chemical compound C=C1CCC2(C(C)C)C1C2 NDVASEGYNIMXJL-UHFFFAOYSA-N 0.000 description 2
- 230000002269 spontaneous effect Effects 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 230000035900 sweating Effects 0.000 description 2
- NPNUFJAVOOONJE-ZIAGYGMSSA-N β-(E)-Caryophyllene Chemical compound C1CC(C)=CCCC(=C)[C@H]2CC(C)(C)[C@@H]21 NPNUFJAVOOONJE-ZIAGYGMSSA-N 0.000 description 2
- NDVASEGYNIMXJL-NXEZZACHSA-N (+)-sabinene Natural products C=C1CC[C@@]2(C(C)C)[C@@H]1C2 NDVASEGYNIMXJL-NXEZZACHSA-N 0.000 description 1
- PFTAWBLQPZVEMU-UKRRQHHQSA-N (-)-epicatechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-UKRRQHHQSA-N 0.000 description 1
- OOCLVMCVOWKECB-UHFFFAOYSA-N 6,6-dimethylbicyclo[3.1.1]heptane-4-carbaldehyde Chemical compound C1C2C(C)(C)C1CCC2C=O OOCLVMCVOWKECB-UHFFFAOYSA-N 0.000 description 1
- NVEQFIOZRFFVFW-UHFFFAOYSA-N 9-epi-beta-caryophyllene oxide Natural products C=C1CCC2OC2(C)CCC2C(C)(C)CC21 NVEQFIOZRFFVFW-UHFFFAOYSA-N 0.000 description 1
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical group CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- 208000000044 Amnesia Diseases 0.000 description 1
- 208000031091 Amnestic disease Diseases 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 102000007592 Apolipoproteins Human genes 0.000 description 1
- 108010071619 Apolipoproteins Proteins 0.000 description 1
- 235000003911 Arachis Nutrition 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 208000002177 Cataract Diseases 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- 241000207892 Convolvulus Species 0.000 description 1
- 241000218176 Corydalis Species 0.000 description 1
- 241001522252 Crassostrea rivularis Species 0.000 description 1
- 241000125183 Crithmum maritimum Species 0.000 description 1
- 240000009138 Curcuma zedoaria Species 0.000 description 1
- 235000003405 Curcuma zedoaria Nutrition 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 206010061818 Disease progression Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 206010014080 Ecchymosis Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 206010015137 Eructation Diseases 0.000 description 1
- QNGQIURXCUHNAT-UHFFFAOYSA-N Eucarvone Chemical compound CC1=CC=CC(C)(C)CC1=O QNGQIURXCUHNAT-UHFFFAOYSA-N 0.000 description 1
- OPQCAZJRIRHZQK-UHFFFAOYSA-N Eucarvone Natural products CC1=CC=CCC(C)(C)C1=O OPQCAZJRIRHZQK-UHFFFAOYSA-N 0.000 description 1
- 241000208686 Eucommiaceae Species 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 206010017577 Gait disturbance Diseases 0.000 description 1
- 208000002705 Glucose Intolerance Diseases 0.000 description 1
- 229940121710 HMGCoA reductase inhibitor Drugs 0.000 description 1
- 208000008899 Habitual abortion Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- 208000007514 Herpes zoster Diseases 0.000 description 1
- 241000237903 Hirudo Species 0.000 description 1
- 239000009636 Huang Qi Substances 0.000 description 1
- 208000035150 Hypercholesterolemia Diseases 0.000 description 1
- 201000001431 Hyperuricemia Diseases 0.000 description 1
- 206010021118 Hypotonia Diseases 0.000 description 1
- 208000026350 Inborn Genetic disease Diseases 0.000 description 1
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 1
- 241000735234 Ligustrum Species 0.000 description 1
- 241000221040 Loranthaceae Species 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 201000002481 Myositis Diseases 0.000 description 1
- 206010028665 Myxoedema Diseases 0.000 description 1
- 206010028851 Necrosis Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000007443 Neurasthenia Diseases 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 241000233855 Orchidaceae Species 0.000 description 1
- 206010033307 Overweight Diseases 0.000 description 1
- 208000018262 Peripheral vascular disease Diseases 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 241001468611 Polygonatum cyrtonema Species 0.000 description 1
- 241000037826 Polygonatum kingianum Species 0.000 description 1
- 241001619461 Poria <basidiomycete fungus> Species 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 201000004681 Psoriasis Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- MUPFEKGTMRGPLJ-RMMQSMQOSA-N Raffinose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 MUPFEKGTMRGPLJ-RMMQSMQOSA-N 0.000 description 1
- 208000001647 Renal Insufficiency Diseases 0.000 description 1
- 206010038372 Renal arteriosclerosis Diseases 0.000 description 1
- 208000037111 Retinal Hemorrhage Diseases 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 241000123889 Rubus chingii Species 0.000 description 1
- 206010039966 Senile dementia Diseases 0.000 description 1
- 206010040007 Sense of oppression Diseases 0.000 description 1
- MBWUSSKCCUMJHO-ZGXDEBHDSA-N Solamargine Chemical compound O([C@@H]1[C@@H](CO)O[C@H]([C@@H]([C@H]1O)O[C@H]1[C@@H]([C@H](O)[C@@H](O)[C@H](C)O1)O)O[C@@H]1CC2=CC[C@H]3[C@@H]4C[C@H]5[C@@H]([C@]4(CC[C@@H]3[C@@]2(C)CC1)C)[C@@H]([C@]1(NC[C@H](C)CC1)O5)C)[C@@H]1O[C@@H](C)[C@H](O)[C@@H](O)[C@H]1O MBWUSSKCCUMJHO-ZGXDEBHDSA-N 0.000 description 1
- MBWUSSKCCUMJHO-DVDUUUGDSA-N Solamargine Natural products O([C@@H]1[C@@H](O)[C@@H](O[C@H]2[C@H](O)[C@H](O)[C@@H](O)[C@H](C)O2)[C@H](CO)O[C@@H]1O[C@@H]1CC=2[C@@](C)([C@@H]3[C@H]([C@H]4[C@@](C)([C@H]5[C@@H](C)[C@@]6(O[C@H]5C4)NC[C@H](C)CC6)CC3)CC=2)CC1)[C@H]1[C@H](O)[C@H](O)[C@@H](O)[C@@H](C)O1 MBWUSSKCCUMJHO-DVDUUUGDSA-N 0.000 description 1
- 241000208292 Solanaceae Species 0.000 description 1
- KNLOWJPFLKGYGQ-UHFFFAOYSA-N Solasodine 3-O-??-L-rhamnopyranosyl (1‘Â∆2)-O-[??-D-glucopyranosyl (1‘Â∆4)]-??-D-glucopyranoside Natural products O1C2(NCC(C)CC2)C(C)C(C2(CCC3C4(C)CC5)C)C1CC2C3CC=C4CC5OC(C(C1O)OC2C(C(O)C(O)C(C)O2)O)OC(CO)C1OC1OC(CO)C(O)C(O)C1O KNLOWJPFLKGYGQ-UHFFFAOYSA-N 0.000 description 1
- QCTMYNGDIBTNSK-UHFFFAOYSA-N Solasonin Natural products O1C2(NCC(C)CC2)C(C)C(C2(CCC3C4(C)CC5)C)C1CC2C3CC=C4CC5OC(C1OC2C(C(O)C(O)C(C)O2)O)OC(CO)C(O)C1OC1OC(CO)C(O)C(O)C1O QCTMYNGDIBTNSK-UHFFFAOYSA-N 0.000 description 1
- QCTMYNGDIBTNSK-QCNFCIKQSA-N Solasonine Natural products O([C@@H]1[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@@H](O)[C@H](C)O2)[C@@H](O[C@@H]2CC=3[C@@](C)([C@@H]4[C@H]([C@H]5[C@@](C)([C@H]6[C@@H](C)[C@@]7(O[C@H]6C5)NC[C@H](C)CC7)CC4)CC=3)CC2)O[C@@H](CO)[C@@H]1O)[C@H]1[C@@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 QCTMYNGDIBTNSK-QCNFCIKQSA-N 0.000 description 1
- UQZIYBXSHAGNOE-USOSMYMVSA-N Stachyose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@H](CO[C@@H]2[C@@H](O)[C@@H](O)[C@@H](O)[C@H](CO)O2)O1 UQZIYBXSHAGNOE-USOSMYMVSA-N 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 241001122767 Theaceae Species 0.000 description 1
- 206010043458 Thirst Diseases 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 241000209140 Triticum Species 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- MUPFEKGTMRGPLJ-UHFFFAOYSA-N UNPD196149 Natural products OC1C(O)C(CO)OC1(CO)OC1C(O)C(O)C(O)C(COC2C(C(O)C(O)C(CO)O2)O)O1 MUPFEKGTMRGPLJ-UHFFFAOYSA-N 0.000 description 1
- 208000012886 Vertigo Diseases 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 210000004404 adrenal cortex Anatomy 0.000 description 1
- 150000001336 alkenes Chemical class 0.000 description 1
- FAMPSKZZVDUYOS-UHFFFAOYSA-N alpha-Caryophyllene Natural products CC1=CCC(C)(C)C=CCC(C)=CCC1 FAMPSKZZVDUYOS-UHFFFAOYSA-N 0.000 description 1
- RCTKRNCKOYYRIO-UHFFFAOYSA-N alpha-Solamarine Natural products O1C2(NCC(C)CC2)C(C)C(C2(CCC3C4(C)CC5)C)C1CC2C3CC=C4CC5OC(C1O)OC(CO)C(O)C1OC1OC(CO)C(O)C(O)C1OC1OC(C)C(O)C(O)C1O RCTKRNCKOYYRIO-UHFFFAOYSA-N 0.000 description 1
- VYBREYKSZAROCT-UHFFFAOYSA-N alpha-myrcene Natural products CC(=C)CCCC(=C)C=C VYBREYKSZAROCT-UHFFFAOYSA-N 0.000 description 1
- MVNCAPSFBDBCGF-UHFFFAOYSA-N alpha-pinene Natural products CC1=CCC23C1CC2C3(C)C MVNCAPSFBDBCGF-UHFFFAOYSA-N 0.000 description 1
- KQAZVFVOEIRWHN-UHFFFAOYSA-N alpha-thujene Natural products CC1=CCC2(C(C)C)C1C2 KQAZVFVOEIRWHN-UHFFFAOYSA-N 0.000 description 1
- 230000006986 amnesia Effects 0.000 description 1
- 210000004381 amniotic fluid Anatomy 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 208000002399 aphthous stomatitis Diseases 0.000 description 1
- 230000004596 appetite loss Effects 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 230000003143 atherosclerotic effect Effects 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- NPNUFJAVOOONJE-UHFFFAOYSA-N beta-cariophyllene Natural products C1CC(C)=CCCC(=C)C2CC(C)(C)C21 NPNUFJAVOOONJE-UHFFFAOYSA-N 0.000 description 1
- 229930006722 beta-pinene Natural products 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 229960001948 caffeine Drugs 0.000 description 1
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 1
- 238000001354 calcination Methods 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 235000001465 calcium Nutrition 0.000 description 1
- 239000010238 camphora Substances 0.000 description 1
- 229940025250 camphora Drugs 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 229940117948 caryophyllene Drugs 0.000 description 1
- NPNUFJAVOOONJE-UONOGXRCSA-N caryophyllene Natural products C1CC(C)=CCCC(=C)[C@@H]2CC(C)(C)[C@@H]21 NPNUFJAVOOONJE-UONOGXRCSA-N 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 206010008118 cerebral infarction Diseases 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 239000001812 curcuma zedoaria berg. rosc. Substances 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000005750 disease progression Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 206010013990 dysuria Diseases 0.000 description 1
- 210000003038 endothelium Anatomy 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 150000002118 epoxides Chemical class 0.000 description 1
- 230000005713 exacerbation Effects 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 208000017561 flaccidity Diseases 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- PQTCMBYFWMFIGM-UHFFFAOYSA-N gold silver Chemical compound [Ag].[Au] PQTCMBYFWMFIGM-UHFFFAOYSA-N 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 210000001624 hip Anatomy 0.000 description 1
- 239000002471 hydroxymethylglutaryl coenzyme A reductase inhibitor Substances 0.000 description 1
- 208000013403 hyperactivity Diseases 0.000 description 1
- 208000020346 hyperlipoproteinemia Diseases 0.000 description 1
- 208000006575 hypertriglyceridemia Diseases 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 201000006370 kidney failure Diseases 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 208000013433 lightheadedness Diseases 0.000 description 1
- 230000037356 lipid metabolism Effects 0.000 description 1
- 208000019017 loss of appetite Diseases 0.000 description 1
- 235000021266 loss of appetite Nutrition 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 208000003786 myxedema Diseases 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 235000021590 normal diet Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 206010034754 petechiae Diseases 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 210000003800 pharynx Anatomy 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 235000014786 phosphorus Nutrition 0.000 description 1
- 201000009104 prediabetes syndrome Diseases 0.000 description 1
- 206010036596 premature ejaculation Diseases 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 201000007094 prostatitis Diseases 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 239000009806 pulsatillae Substances 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- GRWFGVWFFZKLTI-UHFFFAOYSA-N rac-alpha-Pinene Natural products CC1=CCC2C(C)(C)C1C2 GRWFGVWFFZKLTI-UHFFFAOYSA-N 0.000 description 1
- MUPFEKGTMRGPLJ-ZQSKZDJDSA-N raffinose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)O1 MUPFEKGTMRGPLJ-ZQSKZDJDSA-N 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 201000005404 rubella Diseases 0.000 description 1
- 229930006696 sabinene Natural products 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 208000012201 sexual and gender identity disease Diseases 0.000 description 1
- 208000015891 sexual disease Diseases 0.000 description 1
- 208000013220 shortness of breath Diseases 0.000 description 1
- 230000000391 smoking effect Effects 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 241000894007 species Species 0.000 description 1
- UQZIYBXSHAGNOE-XNSRJBNMSA-N stachyose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO[C@@H]3[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O3)O)O2)O)O1 UQZIYBXSHAGNOE-XNSRJBNMSA-N 0.000 description 1
- 231100000240 steatosis hepatitis Toxicity 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- -1 terpinene-4-alcohol Chemical compound 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 208000019553 vascular disease Diseases 0.000 description 1
- 231100000889 vertigo Toxicity 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 230000009978 visual deterioration Effects 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 235000019509 white turmeric Nutrition 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- 235000014101 wine Nutrition 0.000 description 1
- QCTMYNGDIBTNSK-XEAAVONHSA-N α-Solamarine Chemical compound O([C@H]1[C@@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@H](O)[C@@H](O)[C@H](C)O1)O)O[C@@H]1CC2=CC[C@H]3[C@@H]4C[C@H]5[C@@H]([C@]4(CC[C@@H]3[C@@]2(C)CC1)C)[C@@H]([C@]1(NC[C@H](C)CC1)O5)C)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O QCTMYNGDIBTNSK-XEAAVONHSA-N 0.000 description 1
- WTARULDDTDQWMU-UHFFFAOYSA-N β-pinene Chemical compound C1C2C(C)(C)C1CCC2=C WTARULDDTDQWMU-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/46—Eucommiaceae (Eucommia family), e.g. hardy rubber tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/618—Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/39—Convolvulaceae (Morning-glory family), e.g. bindweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/533—Leonurus (motherwort)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
- A61K36/638—Ligustrum, e.g. Chinese privet
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/704—Polygonum, e.g. knotweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/82—Theaceae (Tea family), e.g. camellia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8969—Polygonatum (Solomon's seal)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/898—Orchidaceae (Orchid family)
- A61K36/8984—Dendrobium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9064—Amomum, e.g. round cardamom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/282—Organic compounds, e.g. fats
- A61K9/2826—Sugars or sugar alcohols, e.g. sucrose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Marine Sciences & Fisheries (AREA)
- Zoology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a qi tonifying and meridian unblocking medicament for patients with hyperlipidemia. The medicament is mainly prepared from the following raw materials in parts by weight: 10-15 parts of eucommiae bark, 6-9 parts of black nightshade herb, 5-10 parts of amomum cardamomum, 8-12 parts of motherwort fruit, 10-20 parts of polygonum multiflorum, 12-25 parts of rhizoma polygonati, 6-9 parts of celery root, 8-12 parts of curcuma aromatica, 5-10 parts of parasitic loranthus, 3-6 parts of peanut herb, 8-12 parts of glossy privet fruit, 4-8 parts of tea tree root, 10-20 parts of dendrobe, 10-25 parts of radix polygonati officinalis, 8-16 parts of raspberry, 10-15 parts of seed of Chinese dodder and 4-6 parts of (calcined) oyster. According to the theory of traditional Chinese medicine, various traditional Chinese medicinal materials are adopted and are dialectically combined, so that the medicament disclosed by the invention has the functions of promoting blood circulation and removing stasis, tonifying qi and unblocking meridians, invigorating spleen and removing phlegm, promoting qi circulation and eliminating stagnation, lowering blood lipid and improving blood circulation.
Description
Technical field
The present invention relates to traditional Chinese medicine field, particularly relate to a kind of hyperlipemic patients supplementing qi and invigorating vasculum medicament and preparation method.
Background technology
Because lipid metabolism or running make one or more lipids of blood plasma higher than being normally called hyperlipemia extremely, lipid is insoluble or be slightly soluble in water and must exist with lipoprotein form with protein bound, therefore, hyperlipemia is often hyperlipoproteinemia, show as hypercholesterolemia, hypertriglyceridemia or both have concurrently, directly can cause the disease of some serious harm healths, as atherosclerosis, coronary heart disease, pancreatitis etc.Hyperlipemia can be divided into constitutional and Secondary cases two class.Constitutional is relevant with heredity, is due to single-gene defect or polygenes defect, makes the receptor of the transhipment of participation lipoprotein and metabolism, enzyme or apolipoprotein caused by abnormal, or causes due to environmental factors (diet, nutrition, medicine) with by unknown mechanism.Secondary cases is multiple is born in metabolic disorder disease (diabetes, hypertension, myxedema, obesity, hepatorenal disease, adrenal cortex function are hyperfunction), or with other factor age, sex, drink, smoking, diet, physical exertion, psychentonia etc. be relevant.The clinical manifestation of hyperlipemia is the xanthoma of lipid caused by intradermal deposition and the arteriosclerosis of lipid caused by blood vessel endothelium deposition mainly.Although hyperlipemia can cause xanthoma, its incidence rate is not high; And atherosclerotic generation and development are slowly progressive processes.Therefore under normal conditions, most of patients non-evident sympton and abnormal sign.Many people raise owing to just finding that there is blood plasma lipoprotein level when other reasons carries out blood biochemical inspection.
A large amount of research data shows, hyperlipidemia is the risk factor of apoplexy, coronary heart disease, myocardial infarction, sudden death.In addition, hyperlipidemia is also the important risk factor promoting hypertension, impaired glucose tolerance, diabetes.Hyperlipidemia also can cause fatty liver, liver cirrhosis, cholelithiasis, pancreatitis, retinal hemorrhage, blind, peripheral vascular disease, limping, hyperuricemia.
Hyperlipidemia is the Major Risk Factors causing human atherosclerosis's property disease.Have as common atherosclerosis: coronary heart disease (comprising myocardial infarction, angina pectoris and sudden death), cerebral infarction and peripheral vessels thrombotic disease.The sickness rate of these cardiac and cerebral vascular diseases is high, and harm is large, and disease progression is dangerous, about its mortality rate accounts for the half of mankind's general mortality rate.If hyperlipoidemia, easily cause blood thick, blood vessel wall deposits, form little speckle (being exactly " atherosclerosis " that we often say) gradually, these specklees increase increase, gradually artery-clogging, make blood flow slack-off, time serious, blood flow is interrupted, if this situation occurs in heart just cause coronary heart disease; Occur in brain and just there will be apoplexy; If blocking optical fundus blood vessel will cause visual deterioration, blind; If occur in kidney will cause renal arteriosclerosis, renal failure; Occur in lower limb and there will be limb necrosis, fester.In addition, hyperlipidemia can cause hypertension, brings out cholelithiasis, and pancreatitis increases the weight of hepatitis, causes male sexual disorder, the diseases such as senile dementia, and current research prompting hyperlipidemia may be relevant with the morbidity of cancer.
The Measures compare of existing Chinese traditional treatment hyperlipidemia is many, for the problems referred to above, publication number CN 102526639 A (application number 201210063469.0) patent document discloses a kind of Chinese medicine composition for the treatment of hyperlipidemia and preparation method thereof, comprising: Fructus Crataegi, the Radix Astragali, Semen Lepidii (Semen Descurainiae), Rhizoma Curcumae Longae, Pollen Typhae, Hirudo, Radix Rhapontici, Fructus Ligustri Lucidi, rush down pool, Poria, Herba Dendrobii, Herba Ecliptae, Radix Rubiae, Rhizoma Corydalis and the Radix Pulsatillae.Publication number CN 103301220 A(application number 201310184104.8) patent document discloses a kind of herbal mediciment for the treatment of hyperlipidemia and preparation method thereof, be made up of the raw material making effective ingredient of following weight portion: Andrias davidianus Blanchard meat powder 18-22 part, Radix Polygoni Multiflori Preparata 14-16 part, Fructus Ligustri Lucidi 13-15 part, Herba Taxilli 14-16 part, Fructus Crataegi 18-21 part, its preparation method comprises the following steps: the Andrias davidianus Blanchard after butchering is cleaned, removes the peel, removes internal organs by (1), Andrias davidianus Blanchard is cooked being no more than at the temperature of 90 DEG C, then pick a bone, smash, drying, obtained Andrias davidianus Blanchard meat powder; (2) Radix Polygoni Multiflori Preparata, Fructus Ligustri Lucidi, Herba Taxilli, Fructus Crataegi are boiled risen with adding water big fire, material water weight ratio 1:2-3, then slow fire decocts 30-40 minute, filters; (3) by step (1), (2) gained Andrias davidianus Blanchard meat powder and filtrate mixing, slow fire endures 12-26 minute again.Publication number CN 102670869 A (application number 201210182131.7) patent document discloses a kind of alleviation hyperlipidemia Pollen Typhae Chinese medicine oral liquid and preparation method, is be prepared from by the raw material of Chinese medicine of following parts by weight: Radix Et Rhizoma Rhei 30-50 part, Semen Cassiae 50-100 part, Pollen Typhae 150-300 part, Fructus Ligustri Lucidi 150-300 part, Fructus Mori 150-300 part.
The prior art comprising above-mentioned patent documentation achieves certain achievement in treatment hyperlipidemia, also a lot of medicine is had, Western medicine has advantage that is rapid-action, Be very effective in treatment hyperlipidemia, but side effect is comparatively large, the lipid lowerers as Statins and Bei Te class all likely causes myositis or brain soldier.Current Chinese medicine also exists the difficult problems such as the course of disease is long, refractory is healed, easy recurrence.
Summary of the invention
For the deficiency of existing treatment hyperlipidemia, an object of the present invention is to provide a kind of hyperlipemic patients supplementing qi and invigorating vasculum medicament, there is blood circulation promoting and blood stasis dispelling, supplementing qi and invigorating vasculum, invigorating the spleen for dissipating phlegm, promoting QI to circulate and dispersing the agglomeration of the pathogens, reduction blood fat, improve sanguimotor effect, for hyperlipidemia treatment on have remarkable result, and be free from side effects, treatment cycle is short, not easily recurs.Another object is just to provide the preparation method of above-mentioned hyperlipemic patients supplementing qi and invigorating vasculum medicament.
Above-mentioned purpose of the present invention is achieved through the following technical solutions:
Hyperlipemic patients supplementing qi and invigorating vasculum medicament, takes off the primary raw material stating weight proportion and is prepared from: Cortex Eucommiae 10-15 part; Herba Solani Nigri 6-9 part; Fructus Amomi Rotundus 5-10 part; Fructus Leonuri 8-12 part; Radix Polygoni Multiflori 10-20 part; Rhizoma Polygonati 12-25 part; Root of Herba Apii graveolentis 6-9 part; Radix Curcumae 8-12 part; Herba Taxilli 5-10 part; Semen arachidis hypogaeae herb 3-6 part; Fructus Ligustri Lucidi 8-12 part; Radix Camelliae sinensis 4-8 part; Herba Dendrobii 10-20 part; Rhizoma Polygonati Odorati 10-25 part; Fructus Rubi 8-16 part; Semen Cuscutae 10-15 part; (forging) Concha Ostreae 4-6 part.
Hyperlipemic patients supplementing qi and invigorating vasculum medicament, preferred scheme is, takes off the primary raw material stating weight proportion and is prepared from: Cortex Eucommiae 11-14 part; Herba Solani Nigri 7-8 part; Fructus Amomi Rotundus 6-9 part; Fructus Leonuri 9-11 part; Radix Polygoni Multiflori 13-17 part; Rhizoma Polygonati 17-20 part; Root of Herba Apii graveolentis 7-8 part; Radix Curcumae 9-11 part; Herba Taxilli 6-9 part; Semen arachidis hypogaeae herb 4-5 part; Fructus Ligustri Lucidi 9-11 part; Radix Camelliae sinensis 5-7 part; Herba Dendrobii 13-17 part; Rhizoma Polygonati Odorati 15-20 part; Fructus Rubi 11-13 part; Semen Cuscutae 11-14 part; (forging) Concha Ostreae 4.5-5.5 part.
Hyperlipemic patients supplementing qi and invigorating vasculum medicament, the scheme be more preferably is, takes off the primary raw material stating weight proportion and is prepared from: the Cortex Eucommiae 12 parts; Herba Solani Nigri 7.5 parts; Fructus Amomi Rotundus 8 parts; Fructus Leonuri 10 parts; Radix Polygoni Multiflori 15 parts; Rhizoma Polygonati 18 parts; Root of Herba Apii graveolentis 7.5 parts; Radix Curcumae 10 parts; Herba Taxilli 7 parts; Semen arachidis hypogaeae herb 4.5 parts; Fructus Ligustri Lucidi 10 parts; Radix Camelliae sinensis 6 parts; Herba Dendrobii 15 parts; Rhizoma Polygonati Odorati 17 parts; Fructus Rubi 12 parts; Semen Cuscutae 13 parts; (forging) Concha Ostreae 5 parts.
Present invention also offers the preparation method above-mentioned hyperlipemic patients supplementing qi and invigorating vasculum medicament being made pharmaceutically acceptable decoction, tablet, oral liquid and capsule.
The preparation method of described hyperlipemic patients supplementing qi and invigorating vasculum medicament decoction, step is as follows:
(1) be placed in container by Cortex Eucommiae block, add saline and mix thoroughly, exhaust in rearmounted pot, intense fire is fried to black and fracture of wire sustainability, and with water spray fire extinguishing star, taking-up is dried, and grinds, and crosses 120-160 mesh sieve (preferred cross 130-150 mesh sieve, be more preferably 140 mesh sieves);
(2) Radix Polygoni Multiflori, Rhizoma Polygonati, root of Herba Apii graveolentis, Radix Curcumae and Radix Camelliae sinensis are cut into the preferred 2.5-3.5mm of thick 2-4mm(, be more preferably 3mm) lamellar, be placed in non iron container, add rice wine moistening stand-by (rice wine of preferred 40o-50o is more preferably the rice wine of 45o);
(3) Rhizoma Polygonati Odorati is put into glass container, pour the hot water (the preferably hot water of 75 DEG C-85 DEG C, is more preferably the hot water of 80 DEG C) of 70 DEG C-90 DEG C into, soak 20-40 minute (preferably soak 25-35 minute, be more preferably immersion 30 minutes), filter, filtrate is for subsequent use;
(4) Concha Ostreae (will be forged) to smash, be placed in marmite, add Herba Solani Nigri and Semen Cuscutae, decoct with water 30-50 minute (preferred 35-45 minute, be more preferably 40 minutes), add step (2) gains, step (3) gained filtrate, Fructus Amomi Rotundus, Fructus Leonuri, Herba Taxilli, Semen arachidis hypogaeae herb, Fructus Ligustri Lucidi, Herba Dendrobii and Fructus Rubi, continue decoction twice, boil 20-40 minute (preferred 25-35 minute at every turn, be more preferably 30 minutes), twice filtrate merges, and leaves standstill 3-7 hour (preferred 4-6 hour, be more preferably 5 hours), get supernatant;
(5) step (1) gained fine powder is joined in step (4) gained filtrate, mix homogeneously, filter, sterile packaged.
According to preparation method recited above, preferred scheme is: the consumption of step (1) preferred salt is the 2%-4% of Cortex Eucommiae quality, and the consumption being more preferably salt is 3% of Cortex Eucommiae quality.
Instructions of taking: each 200-300ml, every day 3 times, 7 days courses for the treatment of.
The preparation method of described hyperlipemic patients supplementing qi and invigorating vasculum medicament tablet, step is as follows:
(1) Cortex Eucommiae block is placed in container, add saline and mix that (consumption of preferred salt is the 2%-4% of Cortex Eucommiae quality thoroughly, the consumption being more preferably salt is 3% of Cortex Eucommiae quality), exhaust in rearmounted pot, intense fire is fried to black and fracture of wire sustainability, with water spray fire extinguishing star, taking-up is dried, grind, excessively 120-160 mesh sieve (preferred 130-150 mesh sieve excessively, was more preferably 140 mesh sieves);
(2) Radix Polygoni Multiflori, Rhizoma Polygonati, root of Herba Apii graveolentis, Radix Curcumae and Radix Camelliae sinensis are cut into the preferred 2.5-3.5mm of thick 2-4mm(, be more preferably 3mm) lamellar, be placed in non iron container, add rice wine moistening stand-by (rice wine of preferred 40o-50o is more preferably the rice wine of 45o);
(3) Rhizoma Polygonati Odorati is put into glass container, pour the hot water (the preferably hot water of 75 DEG C-85 DEG C, is more preferably the hot water of 80 DEG C) of 70 DEG C-90 DEG C into, soak 20-40 minute (preferably soak 25-35 minute, be more preferably immersion 30 minutes), filter, filtrate is for subsequent use;
(4) Concha Ostreae (will be forged) to smash, be placed in marmite, add Herba Solani Nigri and Semen Cuscutae, decoct with water 30-50 minute (preferred 35-45 minute, be more preferably 40 minutes), add step (2) gains, step (3) gained filtrate, Fructus Amomi Rotundus, Fructus Leonuri, Herba Taxilli, Semen arachidis hypogaeae herb, Fructus Ligustri Lucidi, Herba Dendrobii and Fructus Rubi, continue decoction twice, boil 20-40 minute (preferred 25-35 minute at every turn, be more preferably 30 minutes), twice filtrate merges, and leaves standstill 3-7 hour (preferred 4-6 hour, be more preferably 5 hours), get supernatant;
(5) step (1) gained fine powder is joined in step (4) gained filtrate, mix homogeneously, being condensed into relative density is 1.20-1.40(45 DEG C) the thick paste of thick paste (being preferably condensed into relative density is 1.25-1.35(45 DEG C), being more preferably and being condensed into relative density is 1.30(45 DEG C) thick paste), make the namely loose soft material that hands pinches agglomerating pressure, make uniform granule, dry, be pressed into lamellar, sugar coating.
Instructions of taking: each 2-3 sheet, every day 3 times, 7 days courses for the treatment of.
The preparation method of described hyperlipemic patients supplementing qi and invigorating vasculum oral medicine liquid, step is as follows:
(1) Cortex Eucommiae block is placed in container, add saline and mix that (consumption of preferred salt is the 2%-4% of Cortex Eucommiae quality thoroughly, the consumption being more preferably salt is 3% of Cortex Eucommiae quality), exhaust in rearmounted pot, intense fire is fried to black and fracture of wire sustainability, with water spray fire extinguishing star, taking-up is dried, grind, excessively 120-160 mesh sieve (preferred 130-150 mesh sieve excessively, was more preferably 140 mesh sieves);
(2) Radix Polygoni Multiflori, Rhizoma Polygonati, root of Herba Apii graveolentis, Radix Curcumae and Radix Camelliae sinensis are cut into the preferred 2.5-3.5mm of thick 2-4mm(, be more preferably 3mm) lamellar, be placed in non iron container, add rice wine moistening stand-by (rice wine of preferred 40o-50o is more preferably the rice wine of 45o);
(3) Rhizoma Polygonati Odorati is put into glass container, pour the hot water (the preferably hot water of 75 DEG C-85 DEG C, is more preferably the hot water of 80 DEG C) of 70 DEG C-90 DEG C into, soak 20-40 minute (preferably soak 25-35 minute, be more preferably immersion 30 minutes), filter, filtrate is for subsequent use;
(4) Concha Ostreae (will be forged) to smash, be placed in marmite, add Herba Solani Nigri and Semen Cuscutae, decoct with water 30-50 minute (preferred 35-45 minute, be more preferably 40 minutes), add step (2) gains, step (3) gained filtrate, Fructus Amomi Rotundus, Fructus Leonuri, Herba Taxilli, Semen arachidis hypogaeae herb, Fructus Ligustri Lucidi, Herba Dendrobii and Fructus Rubi, continue decoction twice, boil 20-40 minute (preferred 25-35 minute at every turn, be more preferably 30 minutes), twice filtrate merges, and leaves standstill 3-7 hour (preferred 4-6 hour, be more preferably 5 hours), get supernatant;
(5) step (1) gained fine powder is joined step (4) gained medicated powder mix homogeneously, be concentrated into 1/2 of original volume, add sodium benzoate and correctives, mixing, sterilize 10-20 minute (preferred 13-17 minute is more preferably 15 minutes), carries out sterile packaged with the dosage often propping up 6ml.
According to preparation method recited above, preferred scheme is: the consumption of step (5) preferred sodium benzoate is the 0.1%-0.3% of concentrated solution quality, correctives uses xylitol, consumption is the 6%-8% of concentrated solution quality, the consumption being more preferably sodium benzoate is 0.2% of concentrated solution quality, correctives uses xylitol, and consumption is 7% of concentrated solution quality.
Instructions of taking: each one, every day 3 times, 7 days courses for the treatment of.
The preparation method of described hyperlipemic patients supplementing qi and invigorating vasculum drug capsule, step is as follows:
(1) Cortex Eucommiae block is placed in container, add saline and mix that (consumption of preferred salt is the 2%-4% of Cortex Eucommiae quality thoroughly, the consumption being more preferably salt is 3% of Cortex Eucommiae quality), exhaust in rearmounted pot, intense fire is fried to black and fracture of wire sustainability, with water spray fire extinguishing star, taking-up is dried, grind, excessively 120-160 mesh sieve (preferred 130-150 mesh sieve excessively, was more preferably 140 mesh sieves);
(2) Radix Polygoni Multiflori, Rhizoma Polygonati, root of Herba Apii graveolentis, Radix Curcumae and Radix Camelliae sinensis are cut into the preferred 2.5-3.5mm of thick 2-4mm(, be more preferably 3mm) lamellar, be placed in non iron container, add rice wine moistening stand-by (rice wine of preferred 40o-50o is more preferably the rice wine of 45o);
(3) Rhizoma Polygonati Odorati is put into glass container, pour the hot water (the preferably hot water of 75 DEG C-85 DEG C, is more preferably the hot water of 80 DEG C) of 70 DEG C-90 DEG C into, soak 20-40 minute (preferably soak 25-35 minute, be more preferably immersion 30 minutes), filter, filtrate is for subsequent use;
(4) Concha Ostreae (will be forged) to smash, be placed in marmite, add Herba Solani Nigri and Semen Cuscutae, decoct with water 30-50 minute (preferred 35-45 minute, be more preferably 40 minutes), add step (2) gains, step (3) gained filtrate, Fructus Amomi Rotundus, Fructus Leonuri, Herba Taxilli, Semen arachidis hypogaeae herb, Fructus Ligustri Lucidi, Herba Dendrobii and Fructus Rubi, continue decoction twice, boil 20-40 minute (preferred 25-35 minute at every turn, be more preferably 30 minutes), twice filtrate merges, and leaves standstill 3-7 hour (preferred 4-6 hour, be more preferably 5 hours), get supernatant;
(5) join in step (4) gained filtrate by step (1) gained fine powder, mix homogeneously, being condensed into relative density is 1.20-1.40(45 DEG C) thick paste, dry, pulverize, obtain medicated powder;
(6) step (5) gained medicated powder is measured according to 0.4-0.6g/ grain (preferred 0.45-0.55g/ grain, is more preferably 0.5g/ grain), be processed into capsule according to the preparation for processing of capsule.
According to preparation method recited above, preferred scheme is: step (5) is preferably concentrated into the thick paste of relative density 1.25-1.35, is more preferably the thick paste being concentrated into relative density 1.30.
Using method: each 2-3 grain, every day 3 times, 7 days courses for the treatment of.
Beneficial effect of the present invention is mainly reflected in:
1, the present invention is according to traditional Chinese medical science traditional theory, and adopt several kinds of Chinese medicinal materials, dialectical compatibility, has blood circulation promoting and blood stasis dispelling, supplementing qi and invigorating vasculum, invigorating the spleen for dissipating phlegm, promoting QI to circulate and dispersing the agglomeration of the pathogens, reduction blood fat, improves sanguimotor effect.
2, the present invention is for hyperlipidemia treatment has remarkable result, and be free from side effects, treatment cycle is short, not easily recurs.
3, facts have proved that this compatibility of drugs is reasonable, synergy is good, effectively can treat hyperlipidemia.
4, the present invention is pure Chinese medicinal preparation, and therapeutic process is simple, decreases patient's slight illness.
Detailed description of the invention
Describe technical scheme of the present invention in detail below in conjunction with embodiment and experimental example, but protection domain is not by this restriction.
embodiment 1hyperlipemic patients supplementing qi and invigorating vasculum medicament, takes off and states primary raw material and be prepared from (getting 50g for every part): the Cortex Eucommiae 10 parts; Herba Solani Nigri 6 parts; Fructus Amomi Rotundus 5 parts; Fructus Leonuri 8 parts; Radix Polygoni Multiflori 10 parts; Rhizoma Polygonati 12 parts; Root of Herba Apii graveolentis 6 parts; Radix Curcumae 8 parts; Herba Taxilli 5 parts; Semen arachidis hypogaeae herb 3 parts; Fructus Ligustri Lucidi 8 parts; Radix Camelliae sinensis 4 parts; Herba Dendrobii 10 parts; Rhizoma Polygonati Odorati 10 parts; Fructus Rubi 8 parts; Semen Cuscutae 10 parts; (forging) Concha Ostreae 4 parts.
The preparation method of above-mentioned hyperlipemic patients supplementing qi and invigorating vasculum medicament decoction, step is as follows:
(1) be placed in container by Cortex Eucommiae block, add saline and mix thoroughly (consumption of salt is 3% of Cortex Eucommiae quality), exhaust in rearmounted pot, intense fire is fried to black and fracture of wire sustainability, and with water spray fire extinguishing star, taking-up is dried, and grinds, and crosses 140 mesh sieves;
(2) Radix Polygoni Multiflori, Rhizoma Polygonati, root of Herba Apii graveolentis, Radix Curcumae and Radix Camelliae sinensis are cut into the lamellar of thick 3mm, are placed in non iron container, add rice wine moistening stand-by (rice wine of preferred 45o);
(3) Rhizoma Polygonati Odorati is put into glass container, pour the hot water of 80 DEG C into, soak 30 minutes, filter, filtrate is for subsequent use;
(4) Concha Ostreae (will be forged) to smash, be placed in marmite, add Herba Solani Nigri and Semen Cuscutae, decoct with water 40 minutes, add step (2) gains, step (3) gained filtrate, Fructus Amomi Rotundus, Fructus Leonuri, Herba Taxilli, Semen arachidis hypogaeae herb, Fructus Ligustri Lucidi, Herba Dendrobii and Fructus Rubi, continue decoction twice, boil 30 minutes at every turn, twice filtrate merges, and leaves standstill 5 hours, gets supernatant;
(5) step (1) gained fine powder is joined in step (4) gained filtrate, mix homogeneously, filter, sterile packaged.
Instructions of taking: each 200-300ml, every day 3 times, 7 days courses for the treatment of.
model case one:literary composition XX, man, 58 years old, Baoding, Hebei province Fuping County people.There is uncomfortable in chest, anterior pectorial region malaise symptoms after fatigue or time angry over 3 years, can alleviate after rest.Once arrive local hospital inspection, be diagnosed as coronary heart disease.After drug administration, symptom is alleviated to some extent, and symptom uncomfortable in chest was interrupted and was occurred period, each outbreak all with nervous, the symptom such as to breathe hard, each lasting about 2-5 minute.That looked into afterwards suffers from hyperlipemia.
After taking 2 courses for the treatment of of gained hyperlipemic patients supplementing qi and invigorating vasculum medicament decoction (embodiment 1) of the present invention, patient is uncomfortable in chest, and palpitation and short breath attack times reduces to some extent, and the mental status is good.After continuing to take 1 course for the treatment of, uncomfortable in chest, palpitation and short breath symptom is obviously improved.Attack times obviously reduces, and degree uncomfortable in chest reduces, and time shorten, can alleviate after rest.After adhering to again taking 2 courses for the treatment of, substantially without sensation of oppression over the chest with shortness of breath symptom.Later stage visits and learns that period is without uncomfortable reaction.
embodiment 2hyperlipemic patients supplementing qi and invigorating vasculum medicament, takes off and states primary raw material and be prepared from (getting 30g for every part): the Cortex Eucommiae 11 parts; Herba Solani Nigri 7 parts; Fructus Amomi Rotundus 6 parts; Fructus Leonuri 9 parts; Radix Polygoni Multiflori 13 parts; Rhizoma Polygonati 17 parts; Root of Herba Apii graveolentis 7 parts; Radix Curcumae 9 parts; Herba Taxilli 6 parts; Semen arachidis hypogaeae herb 4 parts; Fructus Ligustri Lucidi 9 parts; Radix Camelliae sinensis 5 parts; Herba Dendrobii 13 parts; Rhizoma Polygonati Odorati 15 parts; Fructus Rubi 11 parts; Semen Cuscutae 11 parts; (forging) Concha Ostreae 4.5 parts.
The preparation method of above-mentioned hyperlipemic patients supplementing qi and invigorating vasculum medicament tablet, step is as follows:
(1) be placed in container by Cortex Eucommiae block, add saline and mix thoroughly (consumption of preferred salt is 3% of Cortex Eucommiae quality), exhaust in rearmounted pot, intense fire is fried to black and fracture of wire sustainability, and with water spray fire extinguishing star, taking-up is dried, and grinds, and crosses 140 mesh sieves;
(2) Radix Polygoni Multiflori, Rhizoma Polygonati, root of Herba Apii graveolentis, Radix Curcumae and Radix Camelliae sinensis are cut into the lamellar of thick 3mm, are placed in non iron container, add rice wine moistening stand-by (rice wine of preferred 45o);
(3) Rhizoma Polygonati Odorati is put into glass container, pour the hot water of 80 DEG C into, soak 30 minutes, filter, filtrate is for subsequent use;
(4) Concha Ostreae (will be forged) to smash, be placed in marmite, add Herba Solani Nigri and Semen Cuscutae, decoct with water 40 minutes, add step (2) gains, step (3) gained filtrate, Fructus Amomi Rotundus, Fructus Leonuri, Herba Taxilli, Semen arachidis hypogaeae herb, Fructus Ligustri Lucidi, Herba Dendrobii and Fructus Rubi, continue decoction twice, boil 30 minutes at every turn, twice filtrate merges, and leaves standstill 5 hours, gets supernatant;
(5) join in step (4) gained filtrate by step (1) gained fine powder, mix homogeneously, being condensed into relative density is 1.30(45 DEG C) thick paste, make the namely loose soft material that hands pinches agglomerating pressure, make uniform granule, dry, be pressed into lamellar, sugar coating.
Instructions of taking: each 2-3 sheet, every day 3 times, 7 days courses for the treatment of.
model case two:grandson XX, female, 49 years old, Langfang City people from Bazhou City of Hebei province.Suffer from diabetes more than 8 years, recent exacerbation of symptoms, as about fasting glucose 9.4mmol/L, usually there is the symptoms such as weak, nervous, dizzy, the two numbness of lower limbs of companion, hypomnesis, insomnia and dreamful sleep, dry pharynx, dry mouth, local hospital checks blood glucose 10.1mmol/L, blood fat T-CHOL 10.8mmol/L, blood plasma viscosity 3.56mpa.s, is diagnosed as hypertension, hyperlipemia, and treatment has no improvement after half a year.
Friend is listened to introduce gained hyperlipemic patients supplementing qi and invigorating vasculum medicament of the present invention very good to hyperlipidemia therapeutic effect.After taking 2 courses for the treatment of of gained hyperlipemic patients supplementing qi and invigorating vasculum medicament tablet (embodiment 2) of the present invention, blood fat obviously declines, and dizzy, the malaise symptoms such as weak pair of numbness of lower limbs obviously alleviate.After continuing to take 2 courses for the treatment of, dizzy, the malaise symptoms such as weak pair of numbness of lower limbs disappear completely, and blood fat T-CHOL, blood plasma viscosity are down to normally, and blood glucose also declines substantially.
embodiment 3hyperlipemic patients supplementing qi and invigorating vasculum medicament, takes off and states primary raw material and be prepared from (getting 20g for every part): the Cortex Eucommiae 14 parts; Herba Solani Nigri 8 parts; Fructus Amomi Rotundus 9 parts; Fructus Leonuri 11 parts; Radix Polygoni Multiflori 17 parts; Rhizoma Polygonati-20 parts; Root of Herba Apii graveolentis 8 parts; Radix Curcumae 11 parts; Herba Taxilli 9 parts; Semen arachidis hypogaeae herb 5 parts; Fructus Ligustri Lucidi 11 parts; Radix Camelliae sinensis 7 parts; Herba Dendrobii 17 parts; Rhizoma Polygonati Odorati 20 parts; Fructus Rubi 13 parts; Semen Cuscutae 14 parts; (forging) Concha Ostreae 5.5 parts.
The preparation method of above-mentioned hyperlipemic patients supplementing qi and invigorating vasculum oral medicine liquid, step is as follows:
(1) be placed in container by Cortex Eucommiae block, add saline and mix thoroughly (consumption of preferred salt is 3% of Cortex Eucommiae quality), exhaust in rearmounted pot, intense fire is fried to black and fracture of wire sustainability, and with water spray fire extinguishing star, taking-up is dried, and grinds, and crosses 140 mesh sieves;
(2) Radix Polygoni Multiflori, Rhizoma Polygonati, root of Herba Apii graveolentis, Radix Curcumae and Radix Camelliae sinensis are cut into the lamellar of thick 3mm, are placed in non iron container, add rice wine moistening stand-by (rice wine of preferred 45o);
(3) Rhizoma Polygonati Odorati is put into glass container, pour the hot water of 80 DEG C into, soak 30 minutes, filter, filtrate is for subsequent use;
(4) Concha Ostreae (will be forged) to smash, be placed in marmite, add Herba Solani Nigri and Semen Cuscutae, decoct with water 40 minutes, add step (2) gains, step (3) gained filtrate, Fructus Amomi Rotundus, Fructus Leonuri, Herba Taxilli, Semen arachidis hypogaeae herb, Fructus Ligustri Lucidi, Herba Dendrobii and Fructus Rubi, continue decoction twice, boil 30 minutes at every turn, twice filtrate merges, and leaves standstill 5 hours, gets supernatant;
(5) step (1) gained fine powder is joined step (4) gained medicated powder mix homogeneously, be concentrated into 1/2 of original volume, (consumption of sodium benzoate is 0.2% of concentrated solution quality to add sodium benzoate and correctives, correctives uses xylitol, consumption is 7% of concentrated solution quality), mixing, sterilizes 15 minutes, carries out sterile packaged with the dosage often propping up 6ml.
Instructions of taking: each one, every day 3 times, 7 days courses for the treatment of.
model case three:season XX, female, 67 years old, Liaocheng of Shandong Province Linqing City people.In retired employee's health check-up of a unit organization, detect that T-CHOL value is 6.94, be diagnosed as hyperlipidemia.Take him to sting class medicine and carry out blood fat reducing, after half wheat harvesting period, cholesterol has returned to normal level.See that cholesterol recovers normally, stops drug administration, after I had never expected one month, T-CHOL has gone up again, and this makes Mrs Ji very helpless.
After taking 2 courses for the treatment of of gained hyperlipemic patients supplementing qi and invigorating vasculum oral medicine liquid (embodiment 3) of the present invention, symptom slows down to some extent, has carried out blood fat chemical examination, and T-CHOL has dropped to 6.49.After continuing to take 2 courses for the treatment of, T-CHOL has dropped to 5.94, and malaise symptoms also disappears.Later stage visits and learns and there is no malaise symptoms.
embodiment 4hyperlipidemia hard masses softening and resolving medicine, takes off and states primary raw material and be prepared from (getting 20g for every part): the Cortex Eucommiae 12 parts; Herba Solani Nigri 7.5 parts; Fructus Amomi Rotundus 8 parts; Fructus Leonuri 10 parts; Radix Polygoni Multiflori 15 parts; Rhizoma Polygonati 18 parts; Root of Herba Apii graveolentis 7.5 parts; Radix Curcumae 10 parts; Herba Taxilli 7 parts; Semen arachidis hypogaeae herb 4.5 parts; Fructus Ligustri Lucidi 10 parts; Radix Camelliae sinensis 6 parts; Herba Dendrobii 15 parts; Rhizoma Polygonati Odorati 17 parts; Fructus Rubi 12 parts; Semen Cuscutae 13 parts; (forging) Concha Ostreae 5 parts.
The preparation method of above-mentioned hyperlipemic patients supplementing qi and invigorating vasculum drug capsule, step is as follows:
(1) be placed in container by Cortex Eucommiae block, add saline and mix thoroughly (consumption of preferred salt is 3% of Cortex Eucommiae quality), exhaust in rearmounted pot, intense fire is fried to black and fracture of wire sustainability, and with water spray fire extinguishing star, taking-up is dried, and grinds, and crosses 140 mesh sieves;
(2) Radix Polygoni Multiflori, Rhizoma Polygonati, root of Herba Apii graveolentis, Radix Curcumae and Radix Camelliae sinensis are cut into the lamellar of thick 3mm, are placed in non iron container, add rice wine moistening stand-by (rice wine of preferred 45o);
(3) Rhizoma Polygonati Odorati is put into glass container, pour the hot water of 80 DEG C into, soak 30 minutes, filter, filtrate is for subsequent use;
(4) Concha Ostreae (will be forged) to smash, be placed in marmite, add Herba Solani Nigri and Semen Cuscutae, decoct with water 40 minutes, add step (2) gains, step (3) gained filtrate, Fructus Amomi Rotundus, Fructus Leonuri, Herba Taxilli, Semen arachidis hypogaeae herb, Fructus Ligustri Lucidi, Herba Dendrobii and Fructus Rubi, continue decoction twice, boil 30 minutes at every turn, twice filtrate merges, and leaves standstill 5 hours, gets supernatant;
(5) join in step (4) gained filtrate by step (1) gained fine powder, mix homogeneously, being condensed into relative density is 1.30(45 DEG C) thick paste, dry, pulverize, obtain medicated powder;
(6) step (5) gained medicated powder is measured according to 0.5g/ grain, be processed into capsule according to the preparation for processing of capsule.
Instructions of taking: each 2-3 grain, every day 3 times, 7 days courses for the treatment of.
The pharmacological effect of each raw material is respectively:
The Cortex Eucommiae: acrid in the mouth, sweet, warm in nature.For the dry bark of the Eucommiaceae plant Cortex Eucommiae.There is invigorating the liver and kidney, bone and muscle strengthening, antiabortive effect.For spinal column ache, limbs flaccidity is weak, seminal emission, spermatorrhea, Diarrhoea, asthenia, dribbling urination, uncontrolled urination is itched, frequent fetal movement, vaginal bleeding during pregnancy for falling, overabundance of amniotic fluid, habitual abortion, hypertension.
Herba Solani Nigri: bitter in the mouth, micro-sweet, cold in nature.For the aerial parts of plant of Solanaceae Herba Solani Nigri.Containing solasonine, solamargine, β-solamargine etc.There is heat-clearing and toxic substances removing, effect of diuresis.For sore and toxic, skin eczema, dysuria, chronic senile tracheitis, leukorrhagia, prostatitis, dysentery.
Fructus Amomi Rotundus: acrid in the mouth, warm in nature.Return lung, spleen, stomach warp.For the dry mature fruit of zingiberaceous plant Fructus Amomi Rotundus.Containing volatile oil, wherein there are d-Borneolum Syntheticum, d-Camphora, Humuleno and epoxide thereof, 1, 8-Cineole, α-and δ-bat handkerchief alkene, α-and nopinene, caryophyllene, myrcene, myrtanal, Eucarvone, terpinene-4-alcohol, sabinene etc.There is circulation of qi promoting, warming the stomach, help digestion, effect of alleviating distention in middle-JIAO.For the stagnation of QI, dyspepsia, uncomfortable in chest, abdominal distention, eructation, dysphagic, tell inverse, regurgitation, malaria.
Fructus Leonuri: acrid in the mouth, hardship, cold nature.GUIXIN bag, Liver Channel.For the dry mature fruit of labiate Herba Leonuri.There is promoting blood flow to regulate menstruation, effect of liver heat removing and eyesight improving.For menoxenia, amenorrhea, dysmenorrhea, cataract, dizzy distending pain.
Radix Polygoni Multiflori: bitter in the mouth, sweet, puckery. warm in nature.Return liver, the heart, kidney channel.For the dried root of polygonum multiflorum thunb.There is removing toxic substances, disappear de-, effect of loosening bowel to relieve constipation.For scrofula carbuncle sore, rubella pruritus, dryness of the intestine constipation, hyperlipidemia.
Rhizoma Polygonati: sweet in the mouth, property is put down.Return spleen, lung, kidney channel.For the dry rhizome of liliaceous plant P. kingianum, Rhizoma Polygonati or Polygonatum cyrtonema Hua.There is boosting qi and nourishing yin, spleen invigorating, lung moistening, effect of kidney tonifying.For weakness of the spleen and stomach, fatigue and asthenia, xerostomia lack of appetite, deficiency of the lung cough caused by dryness, asthenia of essence and blood, interior-heat is quenched one's thirst.
Root of Herba Apii graveolentis: sweet in the mouth, cool in nature.For the root of samphire Herba Apii graveolentis.Containing more dietary fiber, vitamin and phosphorus, calcium etc.There is promoting blood circulation to remove obstruction in the collateral, removing toxic substances, heat clearing away, diuresis, effect of blood pressure lowering.For hypertension, insomnia, the diseases such as tracheitis.
Radix Curcumae: acrid in the mouth, hardship, cold in nature.For the dried root of zingiberaceous plant RADIX CURCUMAE, Rhizoma Curcumae Longae, Guangxi zedoary or Rhizoma Curcumae.Return liver, the heart, lung meridian.There is regulating qi to disperse stagnation, heart fire-clearing upset-relieving, effect of promoting the function of the gallbladder to alleviate jaundice.For amenorrhea dysmenorrhea, chest and abdomen swelling and pain, twinge, calentura coma, epilepsy is gone mad, jaundice dark coloured urine.
Herba Taxilli: bitter in the mouth, sweet, property is put down.Return liver, kidney channel.For Loranthaceae plant kills the dry stem and branch with leaf of parasitic youngster.There is invigorating the liver and kidney, bone and muscle strengthening, wind-damp dispelling, effect of antiabortive unit.For rheumatic arthralgia, soreness of the waist and knees, muscles and bones is unable, metrorrhagia through many, blood leaking in gestation, frequent fetal movement, hypertension.
Semen arachidis hypogaeae herb: the dry herb of Papilionaceae Arachis annual herb plant Semen arachidis hypogaeae.Have heat clearing away benefit blood, blood pressure lowering, reduces effect of cholesterol.Be used for the treatment of vascular hypertension, neurasthenia, lie awake all night, insomnia and dreamful sleep, be easy to wake up with a start, distending pain in the head, palpitation and amnesia, lack of appetite.
Fructus Ligustri Lucidi: sweet in the mouth, hardship, cool in nature.Return liver, kidney channel.For the fruit of Oleaceae Ligustrum plant Fructus Ligustri Lucidi.There is nourishing the liver and kidney, effect of improving eyesight black hair.For Light-headedness, soreness of the waist and knees, seminal emission, tinnitus, early whitening of beard and hair, osteopyrexia and fever, poor vision.
Radix Camelliae sinensis: bitter in the mouth, property is put down.GUIXIN, kidney channel.For the root of plant of theaceae tea.Containing saccharides such as stachyose, Raffinose, sucrose, glucose, fructose, and containing a small amount of polyphenolic substance (flavonol etc.).Leaf, branch, stem all contain flavonol and caffeine, and content is from leaf to stem all, reduces successively from top to bottom, and stem is containing volume l-epicatechin.There is heart tonifying diuresis, promoting blood flow to regulate menstruation, effect of heat-clearing and toxic substances removing.For heart disease, edema, hepatitis, dysmenorrhea, sore swollen toxin, aphtha, soup fire is burnt, herpes zoster, psoriasis.
Herba Dendrobii: sweet in the mouth, cold nature.For the fresh or dry stem of orchid gold silver five dry measure used in former times, iron sheet building stones or Herba Dendrobii oculati and allied species thereof.Return stomach, kidney channel.There is reinforcing stomach reg fluid, effect of nourishing YIN and clearing away heat.Lose for cloudy impairment of body fluid, xerostomia excessive thirst, lack of appetite is retched, deficiency-heat after being ill, poor vision.
Rhizoma Polygonati Odorati: sweet in the mouth, cold nature.Attach to the lung and stomach meridians.For the dry rhizome of liliaceous plant Rhizoma Polygonati Odorati.There is nourishing YIN to relieve dryness, effect of promoting the production of body fluid to quench thirst.For lung stomach-Yin wound, cough caused by dryness-heat, swallow in thirsty, interior-heat is quenched one's thirst.
Fructus Rubi: sweet in the mouth, acid, warm in nature.Return kidney, urinary bladder channel.For the dry fruit of rosaceous plant rubus chingii Hu.There is kidney tonifying, controlling nocturnal emission with astringent drugs, effect of reducing urination.For enuresis due to deficiency of the kidney, frequent micturition, impotence and premature ejaculation, emission and spermatorrhea.
Semen Cuscutae: sweet in the mouth, warm in nature.Return liver,kidney,spleen warp.For the dry mature seed of convolvulus cuscuta plant.There is nourishing the liver and kidney, controlling nocturnal emission with astringent drugs reducing urination, antiabortive, improving eyesight, effect of antidiarrheal.For impotence and seminal emission, dripping urination, enuresis frequent micturition, soreness of the waist and knees, blurred vision tinnitus, vaginal bleeding due to deficiency of the kidney during pregnancy, frequent fetal movement, spleen is suffered from a deficiency of the kidney and is rushed down; Externally treating leucoderma.
(forging) Concha Ostreae: Concha Ostreae (calcined) is the calcining product of Concha Ostreae, Concha Ostreae salty in the mouth, cold nature.Return liver, gallbladder, kidney channel.For the shell of the long Concha Ostreae of Ostreidae animal, Dalian Bay Concha Ostreae or Crassostrea rivularis.There is tranquillization with heavy prescription, YANG hyperactivity suppressing nourishing YIN, hard masses softening and resolving, restrain astringent or styptic treatment for spontaneous sweating effect.For insomnia of palpitating with fear, vertigo and tinnitus, scrofula sucutaneous nodule , mass in the abdomen mass in the abdomen, spontaneous sweating, seminal emission metrorrhagia and leukorrhagia, stomachache acid regurgitation.
test example:in order to verify the curative effect of gained hyperlipemic patients supplementing qi and invigorating vasculum medicament (embodiment 4) of the present invention, we have done contrast test in April ,-2012 in May, 2008.
General data: the patient screening 200 routine hyperlipidemia in Duo Suo hospital, man 106 example, female 94 example; Minimal ages 36 years old, max age 68 years old, 49.4 years old mean age; 36-50 year 76 people, 50-68 year 124 people; Build overweight people 149 example, medium person 49 example, thin 2 example.The shortest person of the course of disease about 10 days, most elder 4 years.Be divided into experimental group and matched group Liang Ge group (wherein, experimental group 150 people, matched group 50 people) at random.Two groups of ordinary circumstances compare, no significant difference (P > 0.05).
Diagnostic criteria: with reference to " new Chinese medicine guideline of clinical investigations ": (1) Western medicine diagnose standard: in normal diet situation, 2 weeks interior survey for 2 times serum total cholesterol (TC) all >=6.0mmol/L(230mg/dL), or triglyceride (TG) >=1.54mmol/L(140mg/dL), or HDL-C (HDL-C) man≤1.04mmol/L(40mg/dL), female≤1.17mmol/L(45mg/dL) person.(2) Standards of Chinese Medical Syndrome Differentiation: dizzy, headache, uncomfortable in chest, face purple lip is dark, spiritlessness and weakness, extremities being not warm, distension and fullness in the abdomen, indigestion and loss of appetite loose stool, soreness of the waist and knees, dimly red tongue or purple dark or have petechia ecchymosis or have that tooth prints, Tai Bai or greasy in vain, deep-thready pulse or heavy.
Usage and dosage: two groups of patients unify dietary standards (strictly controlling the absorption of wine, meat, sugar).Experimental group takes gained hyperlipemic patients supplementing qi and invigorating vasculum drug capsule of the present invention, each 2, every day 3 times, 7 days courses for the treatment of.Matched group: adopt other treatment mode (as Compound Daushen Lozenge, JIANGZHINING KELI etc.), wherein Compound Daushen Lozenge containing change, one time 2,3 times on the one; JIANGZHINING KELI, oral, a 10g(1 bag), 3 times on the one.
Criterion of therapeutical effect: with reference to " new Chinese medicine guideline of clinical investigations ": cure: clinical symptoms, sign disappear; the every inspection of laboratory recovers normal or lipids detection reaches following any one person: TC declines >=20%; TG declines >=40%; HDL-C rising >=0.26mmol/L (10mg/dL), TC-HDL-C/HDL-C decline >=20%.Effective: clinical symptoms, sign all take a favorable turn, lipids detection reaches following any one person: TC declines >=10% but < 20%, TG declines >=20% but < 40%, HDL-C rising >=0.104mmol/L (4mg/dL) but < 0.26mmol/L (10mg/dL), TC-HDL-C/HDL-C decline >=10% but < 20%.Invalid: after treatment, symptom, sign and lipids detection are without improvement.
5 courses for the treatment of of medication treatment, observe latter 3 months for the treatment of.The Comparison of therapeutic of the matched group adopting other treatment mode and the experimental group taking gained hyperlipemic patients supplementing qi and invigorating vasculum medicament of the present invention, result is as shown in table 1:
Table 1
efficacy analysis:as can be seen from Table 1, take the effective percentage of gained hyperlipemic patients supplementing qi and invigorating vasculum medicament of the present invention up to 96.67%, and adopt other treatment mode only reach 80%, and take the cure rate of gained hyperlipemic patients supplementing qi and invigorating vasculum medicament of the present invention up to 70.67%, and adopt the cure rate of other treatment mode only to reach 46%.Show that the curative effect of gained hyperlipemic patients supplementing qi and invigorating vasculum medicament of the present invention is more remarkable.
Continuous medication treatment chemically examines blood fat after 5 courses for the treatment of, result as shown in Table 2-4:
Table 2 liang group triglyceride (TG) test and comparison (mmol/L)
Two groups of triglyceride (TG) changes: before two groups of treatments, triglyceride (TG) compares P > 0.05, no significant difference; Self compare before and after two groups of treatments, equal P < 0.01; Two groups of difference comparsion P < 0.05 after treatment, and experimental group on average reduce 2.39, matched group on average reduces 1.52, and the normal reference value 0.4-1.86mmol/L of triglyceride (TG), experimental group is taken medicine after 5 courses for the treatment of, the content of triglyceride (TG) is to reach normal level, and matched group does not reach normal level.Therefore experimental group reduction triglyceride (TG) curative effect is better than matched group.
Table 3 liang group serum total cholesterol (TC) test and comparison (mmol/L)
Two groups of serum total cholesterol (TC) changes: before two groups of treatments, serum total cholesterol (TC) compares P > 0.05, no significant difference; Self compare before and after two groups of treatments, equal P < 0.01; Two groups of difference comparsion P < 0.05 after treatment, and the average reduction by 20.63 of experimental group, matched group on average reduces 16.18, and the normal reference value 3.89-6.48mmol/L of serum total cholesterol (TC), experimental group is taken medicine after 5 courses for the treatment of, the content of serum total cholesterol (TC) is to reach normal level, and matched group does not reach normal level.Therefore experimental group reduction serum total cholesterol (TC) curative effect is better than matched group.
Table 4 liang group HDL-C (HDL-C) test and comparison (mmol/L)
Two groups of HDL-C (HDL-C) changes: before two groups of treatments, HDL-C (HDL-C) compares P > 0.05, no significant difference; Self compare before and after two groups of treatments, equal P < 0.01; Two groups of difference comparsion P < 0.05 after treatment, and experimental group on average improve 0.52, matched group on average improves 0.11, and HDL-C (HDL-C) normal reference value 1.04-1.74mmol/L, experimental group is taken medicine after 5 courses for the treatment of, the content of HDL-C (HDL-C) is to reach normal level, and matched group does not reach normal level.Therefore experimental group raising HDL-C (HDL-C) curative effect is better than matched group.
Finally it should be noted that, embodiment is the detailed description of the invention of optimum of the present invention, be not limited to the present invention, although with reference to previous embodiment to invention has been detailed description, for a person skilled in the art, it still can be modified to the technical scheme described in foregoing embodiments, or carries out equivalent replacement to wherein portion of techniques feature.Within the spirit and principles in the present invention all, any amendment done, equivalent replacement, improvement etc., all should be included within protection scope of the present invention.
Claims (10)
1. hyperlipemic patients supplementing qi and invigorating vasculum medicament, is characterized in that, takes off the primary raw material stating weight proportion and is prepared from: Cortex Eucommiae 10-15 part; Herba Solani Nigri 6-9 part; Fructus Amomi Rotundus 5-10 part; Fructus Leonuri 8-12 part; Radix Polygoni Multiflori 10-20 part; Rhizoma Polygonati 12-25 part; Root of Herba Apii graveolentis 6-9 part; Radix Curcumae 8-12 part; Herba Taxilli 5-10 part; Semen arachidis hypogaeae herb 3-6 part; Fructus Ligustri Lucidi 8-12 part; Radix Camelliae sinensis 4-8 part; Herba Dendrobii 10-20 part; Rhizoma Polygonati Odorati 10-25 part; Fructus Rubi 8-16 part; Semen Cuscutae 10-15 part; (forging) Concha Ostreae 4-6 part.
2. hyperlipemic patients supplementing qi and invigorating vasculum medicament according to claim 1, is characterized in that, takes off the primary raw material stating weight proportion and is prepared from: Cortex Eucommiae 11-14 part; Herba Solani Nigri 7-8 part; Fructus Amomi Rotundus 6-9 part; Fructus Leonuri 9-11 part; Radix Polygoni Multiflori 13-17 part; Rhizoma Polygonati 17-20 part; Root of Herba Apii graveolentis 7-8 part; Radix Curcumae 9-11 part; Herba Taxilli 6-9 part; Semen arachidis hypogaeae herb 4-5 part; Fructus Ligustri Lucidi 9-11 part; Radix Camelliae sinensis 5-7 part; Herba Dendrobii 13-17 part; Rhizoma Polygonati Odorati 15-20 part; Fructus Rubi 11-13 part; Semen Cuscutae 11-14 part; (forging) Concha Ostreae 4.5-5.5 part.
3. hyperlipemic patients supplementing qi and invigorating vasculum medicament according to claim 1, is characterized in that, takes off the primary raw material stating weight proportion and is prepared from: the Cortex Eucommiae 12 parts; Herba Solani Nigri 7.5 parts; Fructus Amomi Rotundus 8 parts; Fructus Leonuri 10 parts; Radix Polygoni Multiflori 15 parts; Rhizoma Polygonati 18 parts; Root of Herba Apii graveolentis 7.5 parts; Radix Curcumae 10 parts; Herba Taxilli 7 parts; Semen arachidis hypogaeae herb 4.5 parts; Fructus Ligustri Lucidi 10 parts; Radix Camelliae sinensis 6 parts; Herba Dendrobii 15 parts; Rhizoma Polygonati Odorati 17 parts; Fructus Rubi 12 parts; Semen Cuscutae 13 parts; (forging) Concha Ostreae 5 parts.
4., according to the arbitrary described hyperlipemic patients supplementing qi and invigorating vasculum medicament of claim 1-3, it is characterized in that, be made into pharmaceutically acceptable decoction, preparation method is:
(1) be placed in container by Cortex Eucommiae block, add saline and mix thoroughly, exhaust in rearmounted pot, intense fire is fried to black and fracture of wire sustainability, and with water spray fire extinguishing star, taking-up is dried, and grinds, and crosses 120-160 mesh sieve (preferred cross 130-150 mesh sieve, be more preferably 140 mesh sieves);
(2) Radix Polygoni Multiflori, Rhizoma Polygonati, root of Herba Apii graveolentis, Radix Curcumae and Radix Camelliae sinensis are cut into the preferred 2.5-3.5mm of thick 2-4mm(, be more preferably 3mm) lamellar, be placed in non iron container, add rice wine moistening stand-by (rice wine of preferred 40o-50o is more preferably the rice wine of 45o);
(3) Rhizoma Polygonati Odorati is put into glass container, pour the hot water (the preferably hot water of 75 DEG C-85 DEG C, is more preferably the hot water of 80 DEG C) of 70 DEG C-90 DEG C into, soak 20-40 minute (preferably soak 25-35 minute, be more preferably immersion 30 minutes), filter, filtrate is for subsequent use;
(4) Concha Ostreae (will be forged) to smash, be placed in marmite, add Herba Solani Nigri and Semen Cuscutae, decoct with water 30-50 minute (preferred 35-45 minute, be more preferably 40 minutes), add step (2) gains, step (3) gained filtrate, Fructus Amomi Rotundus, Fructus Leonuri, Herba Taxilli, Semen arachidis hypogaeae herb, Fructus Ligustri Lucidi, Herba Dendrobii and Fructus Rubi, continue decoction twice, boil 20-40 minute (preferred 25-35 minute at every turn, be more preferably 30 minutes), twice filtrate merges, and leaves standstill 3-7 hour (preferred 4-6 hour, be more preferably 5 hours), get supernatant;
(5) step (1) gained fine powder is joined in step (4) gained filtrate, mix homogeneously, filter, sterile packaged.
5. the preparation method of hyperlipemic patients supplementing qi and invigorating vasculum medicament decoction according to claim 4, it is characterized in that: the consumption of step (1) preferred salt is the 2%-4% of Cortex Eucommiae quality, the consumption being more preferably salt is 3% of Cortex Eucommiae quality.
6., according to the arbitrary described hyperlipemic patients supplementing qi and invigorating vasculum medicament of claim 1-3, it is characterized in that, the preparation method of described tablet, step is as follows:
(1) Cortex Eucommiae block is placed in container, add saline and mix that (consumption of preferred salt is the 2%-4% of Cortex Eucommiae quality thoroughly, the consumption being more preferably salt is 3% of Cortex Eucommiae quality), exhaust in rearmounted pot, intense fire is fried to black and fracture of wire sustainability, with water spray fire extinguishing star, taking-up is dried, grind, excessively 120-160 mesh sieve (preferred 130-150 mesh sieve excessively, was more preferably 140 mesh sieves);
(2) Radix Polygoni Multiflori, Rhizoma Polygonati, root of Herba Apii graveolentis, Radix Curcumae and Radix Camelliae sinensis are cut into the preferred 2.5-3.5mm of thick 2-4mm(, be more preferably 3mm) lamellar, be placed in non iron container, add rice wine moistening stand-by (rice wine of preferred 40o-50o is more preferably the rice wine of 45o);
(3) Rhizoma Polygonati Odorati is put into glass container, pour the hot water (the preferably hot water of 75 DEG C-85 DEG C, is more preferably the hot water of 80 DEG C) of 70 DEG C-90 DEG C into, soak 20-40 minute (preferably soak 25-35 minute, be more preferably immersion 30 minutes), filter, filtrate is for subsequent use;
(4) Concha Ostreae (will be forged) to smash, be placed in marmite, add Herba Solani Nigri and Semen Cuscutae, decoct with water 30-50 minute (preferred 35-45 minute, be more preferably 40 minutes), add step (2) gains, step (3) gained filtrate, Fructus Amomi Rotundus, Fructus Leonuri, Herba Taxilli, Semen arachidis hypogaeae herb, Fructus Ligustri Lucidi, Herba Dendrobii and Fructus Rubi, continue decoction twice, boil 20-40 minute (preferred 25-35 minute at every turn, be more preferably 30 minutes), twice filtrate merges, and leaves standstill 3-7 hour (preferred 4-6 hour, be more preferably 5 hours), get supernatant;
(5) step (1) gained fine powder is joined in step (4) gained filtrate, mix homogeneously, being condensed into relative density is 1.20-1.40(45 DEG C) thick paste (be preferably condensed into the thick paste that relative density is 1.25-1.35, be more preferably and be condensed into the thick paste that relative density is 1.30), make the namely loose soft material that hands pinches agglomerating pressure, make uniform granule, dry, be pressed into lamellar, sugar coating.
7., according to the arbitrary described hyperlipemic patients supplementing qi and invigorating vasculum medicament of claim 1-3, it is characterized in that, the preparation method of described oral liquid, step is as follows:
(1) Cortex Eucommiae block is placed in container, add saline and mix that (consumption of preferred salt is the 2%-4% of Cortex Eucommiae quality thoroughly, the consumption being more preferably salt is 3% of Cortex Eucommiae quality), exhaust in rearmounted pot, intense fire is fried to black and fracture of wire sustainability, with water spray fire extinguishing star, taking-up is dried, grind, excessively 120-160 mesh sieve (preferred 130-150 mesh sieve excessively, was more preferably 140 mesh sieves);
(2) Radix Polygoni Multiflori, Rhizoma Polygonati, root of Herba Apii graveolentis, Radix Curcumae and Radix Camelliae sinensis are cut into the preferred 2.5-3.5mm of thick 2-4mm(, be more preferably 3mm) lamellar, be placed in non iron container, add rice wine moistening stand-by (rice wine of preferred 40o-50o is more preferably the rice wine of 45o);
(3) Rhizoma Polygonati Odorati is put into glass container, pour the hot water (the preferably hot water of 75 DEG C-85 DEG C, is more preferably the hot water of 80 DEG C) of 70 DEG C-90 DEG C into, soak 20-40 minute (preferably soak 25-35 minute, be more preferably immersion 30 minutes), filter, filtrate is for subsequent use;
(4) Concha Ostreae (will be forged) to smash, be placed in marmite, add Herba Solani Nigri and Semen Cuscutae, decoct with water 30-50 minute (preferred 35-45 minute, be more preferably 40 minutes), add step (2) gains, step (3) gained filtrate, Fructus Amomi Rotundus, Fructus Leonuri, Herba Taxilli, Semen arachidis hypogaeae herb, Fructus Ligustri Lucidi, Herba Dendrobii and Fructus Rubi, continue decoction twice, boil 20-40 minute (preferred 25-35 minute at every turn, be more preferably 30 minutes), twice filtrate merges, and leaves standstill 3-7 hour (preferred 4-6 hour, be more preferably 5 hours), get supernatant;
(5) step (1) gained fine powder is joined step (4) gained medicated powder mix homogeneously, be concentrated into 1/2 of original volume, add sodium benzoate and correctives, mixing, sterilize 10-20 minute (preferred 13-17 minute is more preferably 15 minutes), carries out sterile packaged with the dosage often propping up 6ml.
8. the preparation method of hyperlipemic patients supplementing qi and invigorating vasculum oral medicine liquid according to claim 7, it is characterized in that: the consumption of step (5) preferred sodium benzoate is the 0.1%-0.3% of concentrated solution quality, correctives uses xylitol, consumption is the 6%-8% of concentrated solution quality, the consumption being more preferably sodium benzoate is 0.2% of concentrated solution quality, correctives uses xylitol, and consumption is 7% of concentrated solution quality.
9., according to the arbitrary described hyperlipemic patients supplementing qi and invigorating vasculum medicament of claim 1-3, it is characterized in that, the preparation method of described capsule, step is as follows:
(1) Cortex Eucommiae block is placed in container, add saline and mix that (consumption of preferred salt is the 2%-4% of Cortex Eucommiae quality thoroughly, the consumption being more preferably salt is 3% of Cortex Eucommiae quality), exhaust in rearmounted pot, intense fire is fried to black and fracture of wire sustainability, with water spray fire extinguishing star, taking-up is dried, grind, excessively 120-160 mesh sieve (preferred 130-150 mesh sieve excessively, was more preferably 140 mesh sieves);
(2) Radix Polygoni Multiflori, Rhizoma Polygonati, root of Herba Apii graveolentis, Radix Curcumae and Radix Camelliae sinensis are cut into the preferred 2.5-3.5mm of thick 2-4mm(, be more preferably 3mm) lamellar, be placed in non iron container, add rice wine moistening stand-by (rice wine of preferred 40o-50o is more preferably the rice wine of 45o);
(3) Rhizoma Polygonati Odorati is put into glass container, pour the hot water (the preferably hot water of 75 DEG C-85 DEG C, is more preferably the hot water of 80 DEG C) of 70 DEG C-90 DEG C into, soak 20-40 minute (preferably soak 25-35 minute, be more preferably immersion 30 minutes), filter, filtrate is for subsequent use;
(4) Concha Ostreae (will be forged) to smash, be placed in marmite, add Herba Solani Nigri and Semen Cuscutae, decoct with water 30-50 minute (preferred 35-45 minute, be more preferably 40 minutes), add step (2) gains, step (3) gained filtrate, Fructus Amomi Rotundus, Fructus Leonuri, Herba Taxilli, Semen arachidis hypogaeae herb, Fructus Ligustri Lucidi, Herba Dendrobii and Fructus Rubi, continue decoction twice, boil 20-40 minute (preferred 25-35 minute at every turn, be more preferably 30 minutes), twice filtrate merges, and leaves standstill 3-7 hour (preferred 4-6 hour, be more preferably 5 hours), get supernatant;
(5) join in step (4) gained filtrate by step (1) gained fine powder, mix homogeneously, being condensed into relative density is 1.20-1.40(45 DEG C) thick paste, dry, pulverize, obtain medicated powder;
(6) step (5) gained medicated powder is measured according to 0.4-0.6g/ grain (preferred 0.45-0.55g/ grain, is more preferably 0.5g/ grain), be processed into capsule according to the preparation for processing of capsule.
10. the preparation method of hyperlipemic patients supplementing qi and invigorating vasculum drug capsule according to claim 9, is characterized in that: step (5) is preferably concentrated into the thick paste of relative density 1.25-1.35, is more preferably the thick paste being concentrated into relative density 1.30.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510063562.5A CN104547960A (en) | 2015-02-09 | 2015-02-09 | Qi tonifying and meridian unblocking medicament for patients with hyperlipidemia and preparation method of medicament |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510063562.5A CN104547960A (en) | 2015-02-09 | 2015-02-09 | Qi tonifying and meridian unblocking medicament for patients with hyperlipidemia and preparation method of medicament |
Publications (1)
Publication Number | Publication Date |
---|---|
CN104547960A true CN104547960A (en) | 2015-04-29 |
Family
ID=53065731
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510063562.5A Pending CN104547960A (en) | 2015-02-09 | 2015-02-09 | Qi tonifying and meridian unblocking medicament for patients with hyperlipidemia and preparation method of medicament |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104547960A (en) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1575809A (en) * | 2003-07-28 | 2005-02-09 | 陈文华 | Antilipemic Chinese herbal medicine |
KR20100022539A (en) * | 2008-08-20 | 2010-03-03 | 서왕식 | The composition of drug for improvement of impotency and circulation of blood |
CN103860699A (en) * | 2014-01-28 | 2014-06-18 | 湖州农富缘生态农庄 | Pharmaceutical composition for radically treating hypertension, hyperlipidemia and hyperglycemia |
-
2015
- 2015-02-09 CN CN201510063562.5A patent/CN104547960A/en active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1575809A (en) * | 2003-07-28 | 2005-02-09 | 陈文华 | Antilipemic Chinese herbal medicine |
KR20100022539A (en) * | 2008-08-20 | 2010-03-03 | 서왕식 | The composition of drug for improvement of impotency and circulation of blood |
CN103860699A (en) * | 2014-01-28 | 2014-06-18 | 湖州农富缘生态农庄 | Pharmaceutical composition for radically treating hypertension, hyperlipidemia and hyperglycemia |
Non-Patent Citations (4)
Title |
---|
于继珍: "《中医专病专治秘方精要 第四卷》", 31 October 2006, 新疆科学技术出版社 * |
倪青 等: "《常用临床药物手册》", 30 September 1999, 中国医药科技出版社 * |
姚克裘: "《高血脂症》", 28 February 2005, 上海科学普及出版社 * |
陈福如: "《医学探微》", 31 January 2013, 海天出版社 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102205107B (en) | Chinese medicinal preparation for treating duodenal ulcer and preparation method thereof | |
CN101797326B (en) | Chinese materia medica preparation for treating borborygmus diarrhoea and preparation method thereof | |
CN103099959B (en) | Traditional Chinese medicine preparation for treating ulcerative colitis and preparation method thereof | |
CN105749179A (en) | Traditional Chinese medicine composition for treating metabolic syndrome | |
CN104958607A (en) | Traditional Chinese medicine composition for treating burning mouth syndromes of climacteric women and preparation method thereof | |
US10485834B2 (en) | Chinese herbal oral paste for conditioning phlegm-dampness constitution and processing method thereof | |
CN104815318A (en) | Traditional Chinese medicine preparation for treating gout | |
CN106994141B (en) | Traditional Chinese medicine composition for treating constipation and preparation method thereof | |
CN106491972A (en) | A kind of anti-antipodagric Chinese medicinal healthcare tea and preparation method thereof | |
CN105232987A (en) | Traditional Chinese medicine promoting neurosurgery postoperative rehabilitation | |
CN104857210A (en) | Traditional Chinese medicine combination preparation for treating fatty liver and preparation method thereof | |
CN105999058B (en) | Bidens bipinnata lipid-lowering tablet | |
CN102133369B (en) | Traditional Chinese medicine composition for treating acute cholecystitis | |
CN104306929A (en) | Traditional Chinese medicine formula for treating severe acute pancreatitis and preparation method of traditional Chinese medicine formula | |
CN103520652B (en) | Traditional Chinese medicine composition for treating liver cancer | |
CN104689239A (en) | Traditional Chinese medicine composition for treating cholelithiasis and preparation method thereof | |
CN104623544A (en) | Traditional Chinese medicine preparation capable of tonifying spleen and eliminating dampness for treating moderate fatty liver and preparation method of traditional Chinese medicine preparation | |
CN104547960A (en) | Qi tonifying and meridian unblocking medicament for patients with hyperlipidemia and preparation method of medicament | |
CN107854588A (en) | A kind of Chinese medicine composition for treating fatty liver and preparation method thereof | |
CN104056231B (en) | A kind of Chinese medicine composition of cooperation western medical treatment senile skin pruritus | |
CN102631481B (en) | Chinese medicinal preparation for treating viral hepatitis | |
CN110812468B (en) | Gymnadenia conopsea-37-flavor Mongolian medicinal ointment formula and preparation method thereof | |
CN104906467A (en) | Traditional Chinese medicine composition for treating gout and preparation method | |
CN105497546A (en) | Traditional Chinese medicine composition for treating internal hemorrhoids and preparation method | |
CN104435152A (en) | Traditional Chinese medicine agent with functions of tranquilizing and allaying excitement for treating stage I of hypertension and preparation method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB02 | Change of applicant information |
Address after: 338000 Jiangxi Province, Xinyu City Yushui District victory road No. 279 Building No. 5 1-801 Applicant after: Wang Shiguo Address before: Kang Hong Lu 250000 Shandong province Ji'nan city high tech Development Zone No. 769 Applicant before: Wang Shiguo |
|
COR | Change of bibliographic data | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20150429 |
|
RJ01 | Rejection of invention patent application after publication |